Antimicrobial drugs that target human - not microbial - genotypes or phenotypes: A paradigm change in human evolutionary response to pathogen selection pressure

Medical Hypotheses

Volumn 67, Issue 2, 2006, Pages 359-361

  Apte, S P ^a   Apte, P P ^a  

^a Chemologic LLC NA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATHEPSIN; CHEMOKINE RECEPTOR CCR5; FLUDASE; N ACETYLGLUCOSAMINYLTRANSFERASE; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

AEROMONAS HYDROPHILA; ALZHEIMER DISEASE; ARTICLE; CHO CELL; CRIGLER NAJJAR SYNDROME; DNA SYNTHESIS; DRUG TARGETING; EBOLA VIRUS; ENDOSYMBIONT; EVOLUTION; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENOTYPE; GILBERT DISEASE; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPOTHESIS; IMMUNE SYSTEM; MICROORGANISM; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROKARYOTE; REOVIRUS; SALMONELLA TYPHI; SURVIVAL; VIBRIO CHOLERAE;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE; EVOLUTION, MOLECULAR; GENOME, HUMAN; GENOTYPE; HUMANS; PHENOTYPE; SELECTION (GENETICS);

PROKARYOTA;

EID: 33744779066     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.01.043     Document Type: Article

References (26)

1. Livermore D.M. Bacterial resistance: origins, epidemiology and impact. Infect Disease 36 Suppl. (2003) S11-S23
2. Caporale L.H. Natural selection and the emergence of a mutation phenotype: an update on the evolutionary synthesis considering mechanisms that affect genome variation. Ann Rev Microb 57 (2003) 467-485
3. Negri M.C., Morosini M.I., Baquero M.R., Campo R.D., Blazques J., and Baquero F. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumonia populations. Antimicrob Agents Chemother 46 2 (2002) 528-530
4. Haldane J.B. Disease and evolution. Ricerca Sci Suppl 19 (1949) 68-76
5. Martinez J.L., and Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity and antibiotic resistance. Clin Microbiol Rev 15 (2002) 647-679
6. Vallender E.J., and Lahn B.T. Positive selection on the human genome. Hum Mol Genet 13 2 (2004) R245-R254
7. Kwiatkowski D. Genetic susceptibility to malaria getting complex. Curr Opin Genet Dev 10 (2000) 320-324
8. Pier G.B., Grout M., Zaidi T., Meluleni G., Mueschenborn S.S., Banting G., et al. Salmonella typhi uses CFTR to enter intestinal epithelial cells. Nature 393 (1998) 79-82
9. Romeo G., Devoto M., and Galietta L.J.V. Why is the cystic fibrosis gene so frequent?. Hum Genet 84 (1989) 1-5
10. Stephens J.C., Reich D.E., Goldstein D.B., Shin H.D., Smith M.W., Carrington M., et al. Dating the origin of the CCR5-delta 32 AIDS resistance allele by the coalescence of haplotypes. Am J Hum Genet 62 (1998) 1507-1515
11. Galvani A.P., and Slatkin M. Evaluating plague and smallpox as historical selective pressures for the CCR5-delta 32 HIV resistance allele. Proc Natl Acad Sci USA 100 25 (2003) 15276-15279
12. Ebert D.H., Kopecky-Bromberg S.A., and Dermody T.S. Cathepsin B is inhibited in mutant cells selected during persistent reovirus infection. J Biol Chem 279 5 (2004) 3837-3851
13. Chandran K., Sullivan N.J., Felbor U., Whelan S.P., and Cunningham J.M. Science (2005) 10.1126/science.1110656
14. Hong Y., Ohishi K., Inoue N., Kang J.Y., Shime H., Hariguchi Y., et al. Requirement of N-glycan on GPI-anchored proteins for efficient binding of aerolysin but not Clostridium septicum alpha toxin. EMBO J 21 (2002) 5047-5056
15. Whittaker C.R., and Chu V.C. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci USA 101 52 (2004) 18153-18158
16. Lederberg J. Infectious disease as an evolutionary paradigm. Emerg Infect Dis 3 4 (1997) 417-423
17. Waddington C.H. Canalization of development and the inheritance of acquired characteristics. Nature 3811 (1942) 563-565
18. Nesse R.M., and Williams G.C. Why we get sick. The new science of Darwinian medicine (1996), Vintage books, NY. 0-8129-2224-7
19. Earl D.J., and Deem M.W. Evolvability is a selectable trait. Proc Natl Acad Sci USA 101 32 (2004) 11531-11536
20. Yazdanbakhsh M., Kremsner P.G., and Van Ree R. Immunology - allergy, parasites, and the hygiene hypothesis. Science 296 (2002) 490-494
21. Samakoglu S., Lisowski L., Budak-Alpdogan T., Usachenko Y., Acuto S., Di Marzo R., et al. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol (2005) [epub ahead of print]
22. Perez E, Jouvenot Y, Urnov F, Holmes M, Beausejour C, Rock J, et al. Use of engineered zinc finger based endonucleases to create CCR5 targeted gene disruption in T cells as potential therapy of HIV/AIDS. In: twelfth conference on retroviruses and opportunistic infections, Feb 22-25, Boston, MA. 2005 (abstract number 521).
23. Shay J.W., and Wright W.E. Telomeres and telomerase: implications for cancer and aging. Radat Res 155 (2001) 188-193
24. Baur J., Zou Y., Shay J.W., and Wright W.E. Telomere position in human cells. Science 292 (2001) 2075-2077
25. Tagawa K., Kunishita T., Maruyama K., Yoshikawa K., Kominami E., Tsuchiya T., et al. Alzheimer's disease amyloid beta-clipping enzyme - (APP-secretase): identification, purification and characterization of the enzyme. Biochem Biophys Res Commun 177 1 (1991) 377-387
26. Kadakol A., Ghosh S.S., Sappal B.S., Sharma G., Chowdhury J., and Roy Chowdhury N. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat 16 (2000) 297-306